摘要
最近对广东省13889名年满20岁的居民进行调查的结果显示,原发性高血压(高血压)的患病率为20.5%,这意味着广东省有980万高血压患者。广东省农村高血压患者患病率、知晓率、治疗率和控制率分别是16.1%,17.6,10.4和3.4%,血压管理的形势是严峻的。在血压管理中,药物治疗对高血压控制率的提高起着至关重要的作用。随着抗高血压药物增多,
出处
《岭南心血管病杂志》
2013年第1期17-23,共7页
South China Journal of Cardiovascular Diseases
参考文献29
-
1MA W J , TANG J L, ZHAING Y H , et al. Hypertensionprevalence, awareness , treatment, control, and associatedfactors in adults in Southern China [ J ]. Am J Hypertens ,2012, 25(5): 590-596.
-
2HOLLANDER % , WILKINS R W. Chlorothiazide: a new typeof drug for the treatment of arterial hypertension [J]. BMQ,1957,8(3):69-75.
-
3KERREIHA S H,GKKKNE L J, ALABASTER V A, et al.Activity of various fractions of bradykinin potentiating factoragainst angiotensin I converting enzyme [ J j. Nature , 1970,225(5230):379-380.
-
4HJALMAHSON A, ELMFEI.DT D, HERTiTZ J, et al. Effecton mortality of metoprolol in actue myocardial infarclion. Adouble-blind randomized trial [ J ]. Lancet, 1981 , 2 (8251):823-827.
-
5MIRC trial of treatmenl ol mild hypertension : principal results.Medical Research Council Working Party [J]. Br Med J(Clin ResEd), 1985, 291(6488) : 97-104.
-
6WILHKLMSKN L, BERGLUND G,ELMFELDT 0, et al. Beta-blockers versus diuretics in hypertensive men : main results fromthe HAPPHY trial[J]. J Hypertens, 1987 ,5 (5 ) : 561-572.
-
71988 Joint National Committee.The 1988 report of the JointNational Committee on Detection , Evaluation , and Treatment ofHigh Blond Pressure [ J]. Arch Intern Med , 1988 , 148 (5):1023-1038.
-
8Hie Joint National Committee on Detection , Evaluation , andTreatment of High Blood Pressure. The fifth report of the JointNational Committee on Deleclion, Evaluation , and Treatmentof High Blood Pressure (JNC V ) [J]. Arch intern Med, 1993 ,153(2): 154-183.
-
9The sixth report of the Joint National Committee on Prevention ,Detection,Evaluation , and Treatment of High Blood Pressure;J J. Arch Intern Med, 1997, 157(21): 2413-2446.
-
10CHOBANIAN A V,BAKRIS G L, BLACK H R, et al. TheSeventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure :the JNC 7 report[Jj. JAMA, 2003,289( 19) ; 2560-2572.
同被引文献36
-
1张静,刘洋.高血压病人的用药指导[J].社区医学杂志,2006,4(08X):24-26. 被引量:12
-
2陈新谦,金有豫,汤光.新编药物学[M].北京:人民卫生出版社,2011:609-621.
-
3Cicek Y,Durakoglugil ME,Kocaman SA,et al.Non-dipping pattern inuntreated hypertensive patients is related to increased pulse wavevelocity independent of raised nocturnal blood pressure[J].BloodPress.2013,22(1):34-38.
-
4Ermis N,Yagmur J,Acikgoz N,et al.Serum gamma-glutamyl trans-ferase(GGT) levels and inflammatory activity in patients with non-dipperhypertension[J].Clin Exp Hypertens.2012;34(5):311-315.
-
5Pawel Salwa,Iwona Gorczyca-Michta,Maciej Kluk,et al.Variability ofcircadian blood pressure profile during 24-hour ambulatory blood pressuremonitoring in hypertensive patients[J],Kardiologia Polska,2014,72(5):432-437.
-
6Hata J,Arima H,Rothwell P M,et al.Effects of Visit-to-VisitVariability in Systolic Blood Pressure on Macrovascular and MicrovascularComplications in Patients With Type 2 Diabetes Mellitus The ADVANCETrial[J].Circulation,2013,128(12):1325-1334.
-
7Yokota K,Fukuda M,Matsui Y,et al.Impact of visit-to-visit variabilityof blood pressure on deterioration of renal function in patients withnon-diabetic chronic kidney disease[J].Hypertens Res,2013,36(2):151-157.
-
8Mizuno M,Fukuda M,Miura T,et al.Morning hypertension in chronic kidneydisease is sustained type,but not surge type[J].Blood Press Monit,2012,17(1):20-23.
-
9Henskens LH,van BMP,Kroon AA,et al.Subjective sleep disturbanceincreases the nocturnal blood pressure level and attenuates the correlationwith target-organ damage[J].J Hypertens,2011,29(2):242-250.
-
10张石革,王文.抗高血压药联合治疗的进展与评价——心血管疾病合理用药专家圆桌会议纪要[J].中国医院用药评价与分析,2011,11(2):97-99. 被引量:7
引证文献6
-
1刘俊.2011~2013年我院抗高血压药物的应用分析[J].西北药学杂志,2015,30(1):93-95. 被引量:6
-
2杨冬梅,刘俊,刘建军.安徽省5家县级公立医院药品集中招标采购前后抗高血压药物使用情况分析[J].蚌埠医学院学报,2015,40(11):1551-1553. 被引量:1
-
3关宏弟,牟建军.老年单纯收缩期高血压患者24h平均脉压与肾功能关系[J].当代医学,2016,22(29):27-28. 被引量:2
-
4马玉红.抗高血压药物的临床效果分析[J].北方药学,2017,14(8):89-90. 被引量:2
-
5何芝玲.高血压病控制疗效分析[J].中国卫生产业,2018,15(2):172-173.
-
6唐杨玲,杨军,王爽,王淑男,姚懿桐,郑林依,董天崴.高血压病药物治疗发展历程与展望[J].中华临床医师杂志(电子版),2017,11(8):1375-1378. 被引量:2
二级引证文献13
-
1徐宏.门诊用药指导对高血压患者临床疗效和依从性的影响[J].世界最新医学信息文摘,2020(15):90-90. 被引量:1
-
2吕宏伟.某院2014年中老年抗高血压处方分析[J].中国现代药物应用,2015,9(21):178-179. 被引量:2
-
3高飞,李军,董少红,麦爱欢,张卓慧.氨氯地平联合氢氯噻嗪对老年高血压患者平稳降压和靶器官的保护作用研究[J].中国医药,2016,11(2):185-188. 被引量:12
-
4刘永,王新玲.依达拉奉联合左旋氨氯地平治疗高血压脑梗死的疗效观察[J].西北药学杂志,2016,31(4):412-414. 被引量:9
-
5李青,刘文莉,杜丽丽,帖丽丽.ACEI联合ARB治疗中重度原发性高血压的临床研究[J].西北药学杂志,2016,31(5):514-517. 被引量:4
-
6汪蜜,肖林,何文富.2012~2015年安神类中成药使用情况分析[J].西北药学杂志,2017,32(4):525-527. 被引量:12
-
7李国英,陈良,刘军.某综合医院2014~2016年降血压类中成药使用分析[J].西北药学杂志,2018,33(5):706-709. 被引量:12
-
8罗伟华,唐毓启.老年单纯收缩期高血压临床诊疗研究进展[J].当代医学,2019,25(2):184-186. 被引量:1
-
9王亚.对中老年人使用抗高血压药物的调查分析[J].临床医药文献电子杂志,2019,6(72):164-164.
-
10王晓媚,陈丽,韩兆洋,卫娜,徐阳,艾美梅.组蛋白去乙酰化酶8抑制剂与硝苯地平联用对左旋硝基精氨酸诱导的高血压大鼠降压效果[J].西部医学,2019,31(12):1851-1855. 被引量:2
-
1黄宗陵.高血压的药物治疗现状[J].医学信息(云南),1994(10):11-14.
-
2潘彩虹.甲基强的松龙用于慢性阻塞性肺病急性加重期的疗效观察[J].中国实用医药,2011,6(6):186-187. 被引量:3
-
3邓伟吾.支气管哮喘的治疗进展[J].中国临床医学杂志,2000,7(2):125-127. 被引量:2
-
4石晶,刘国树.高血压病的药物治疗:从阶梯疗法走向个体化用药[J].实用心脑肺血管病杂志,1993,1(3):94-95.
-
5陈飞南,康松泉,康萍.高血压病中西医结合阶梯疗法的血液流变学观察[J].贵阳中医学院学报,1992,14(2):39-40.
-
6徐启河,郑桂风.高血压个体化阶梯疗法的理论与实践[J].临床荟萃,1992,7(7):314-317. 被引量:5
-
7罗建华.化湿、祛瘀、固本阶梯疗法治疗消化性溃疡40例[J].中国中医药现代远程教育,2014,12(3):26-27. 被引量:1
-
8侯郁阜.阿托品阶梯疗法防治中间综合征的临床观察[J].现代医药卫生,2003,19(7):870-870.
-
9李惠萍,何国钧,褚海青,赵兰,余慧.甲泼尼龙阶梯疗法在慢性阻塞性肺疾病急性加重期的应用价值[J].中华急诊医学杂志,2003,12(10):701-702. 被引量:5
-
10马中书,邱明才.2型糖尿病治疗最佳方案——胰岛素阶梯疗法[J].糖尿病新世界,2000,0(1):26-26.